SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syngene International plans to invest $200 million for expansion

23 Feb 2016 Evaluate

In a bid to expand capacity and upgrade manufacturing facilities, Syngene International is planning to invest $200 million over the next two years.

The investment areas for the capital expenditure are research centre, formulation centre, manufacturing facilities and expansion of new capabilities. The company will tap a mixture of its own resources and debt to raise funds for future growth. Future funding requirements will be met through internal accruals and debt.

Syngene International offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.

Syngene Internatl. Share Price

436.10 -6.85 (-1.55%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internatl. 436.10
Indegene 519.10
CMS Info Systems 291.40
JITF Infralogistics 315.55
Sagility 40.36
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: